Gadolinium Deposition Disease affects patients who have been treated with gadolinium-based contrast agents during magnetic resonance imaging (MRI) and magnetic resonance angiography (MRA) tests. Gadolinium is a dye made from a toxic heavy metal that is injected in more than 20 million MRI/MRA patients every year.
For some patients, Gadolinium can remain in the body for long periods while accumulating on their bones, organs and brain. Most people expel the substance naturally, but for others it can cause multiple health problems that are called Gadolinium Deposition Disease. Companies that have been sued for their role in manufacturing and marketing gadolinium include McKesson Corp., Bracco Diagnostics Inc., Guerbet LLC, Merry X-Ray Chemical Company, and many others.
Gadolinium Deposition Disease has been linked to:
- Nephrogenic Systemic Fibrosis
- Bone Pain
- Joint Pain
- Burning Sensation
- “Brain Fog”
- Extreme Headache
- Extensive Internal Pain
For decades, Allen & Nolte has proudly represented clients in pharmaceutical cases like those involving Gadolinium Deposition Disease. If you or a loved one have suffered additional health problems after an MRI/MRA, please contact us for more information about we can help you.